Summit Therapeutics Inc.
SMMT
$16.18
$0.060.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -258.11% | -312.05% | -836.84% | -44.72% | -67.37% |
| Total Depreciation and Amortization | 90.91% | 110.00% | 85.00% | -7.41% | -26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 725.04% | 670.97% | 1,859.79% | -13.25% | 55.11% |
| Change in Net Operating Assets | 1,315.16% | -12.36% | 614.21% | -247.36% | -108.00% |
| Cash from Operations | -109.43% | -207.23% | -102.24% | -102.99% | -150.13% |
| Capital Expenditure | -1,071.43% | -22.41% | 100.00% | -10,450.00% | -600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -680.86% | 100.00% | 175.40% | 707.71% | 37.85% |
| Cash from Investing | -681.15% | 99.93% | 175.37% | 705.75% | 37.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 64,519.48% | -87.91% | -98.89% | 1,482.89% | -87.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,530.21% | -83.44% | -98.89% | 1,482.89% | -477.67% |
| Foreign Exchange rate Adjustments | 82.41% | -80.70% | 408.33% | 205.56% | -139.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.88% | -190.77% | 362.80% | 1,186.78% | -76.72% |